Notice of Proposed Sale · 144

Accendra Health, Inc.

ACHNYSEEQUITYCurrent

Notice of Proposed Sale

Filed Sep 11, 2026Accepted Sep 11, 2026, 4:30 PM EDTFiling CIK 75252Accession 0001193125-26-389327

View company →Permanent SEC source ↗

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer: Accendra Health, Inc.
Issuer CIK: 0000075252
SEC file number: 001-09810
Phone: 804-277-4304
Person for whose account securities are to be sold: Coliseum Capital Management, LLC
Relationships to issuer: 10% Stockholder
Street: 4435 Waterfront Drive
Street (continued): Suite 300
City: Glen Allen
State / country code: VA
Postal code: 23060

Securities proposed for sale

Securities proposed for sale · 2 reported rows
Security	Proposed units	Aggregate market value	Units outstanding	Approximate sale date	Exchange	Broker / market maker
Common Stock	10,726,759	11,584,899.72	76,904,704	09/11/2026	NYSE	JonesTrading Institutional Services LLC
Common Stock	10,726,759	11,584,899.72	76,904,704	09/11/2026	NYSE	Virtu Americas LLC

Broker / market maker — proposed row 1, entry 1

Name: JonesTrading Institutional Services LLC
Street: 555 Saint Charles Drive
City: Thousand Oaks
State / country code: CA
Postal code: 91360

Broker / market maker — proposed row 2, entry 1

Name: Virtu Americas LLC
Street: 1633 Broadway
City: New York
State / country code: NY
Postal code: 10019

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
Security	Acquired	Nature of acquisition	Acquired from	Amount acquired	Gift transaction	Payment date	Nature of payment
Common Stock	07/31/2024	Open Market Purchases. Please refer to explanatory notes under "Remarks" below.	Open Market Purchases. Please refer to explanatory notes under "Remarks" below.	10,726,759	N	07/31/2024	Cash

Prior-sale reporting

Nothing to report for the preceding three months: Y

Remarks

The securities referred to in this Form 144 are held directly by (a) Coliseum Capital Partners, L.P., an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM. Christopher Shackelton and Adam Gray are managers of and have an ownership interest in each of CCM and CC. Regarding the "Securities To Be Sold" table, the dates of acquisition and dates of payment varied, with purchases commencing on July 31, 2024 and ceasing on August 14, 2025.

Notice signature

Notice date: 09/11/2026
Signed: Chivonne Cassar, as Attorney-in-Fact

Company context

Accendra Health, Inc. (NYSE: ACH) is a leading nationwide provider of products, technology, and services that support health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex health conditions. Backed by the industry-leading expertise of our Apria and Byram brands, Accendra Health is reimagining the future of home-based care. To learn more about our broad portfolio of essentials for diabetes, sleep health, wound care, respiratory care, urology, and ostomy, visit www.accendrahealth.com.

Current securities

ACHNYSE · EQUITY · Current

Get the free weekly BCS email.